Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL9643 in Dry Eye Disease
NCT05201170Phase 3Completed
- Sponsor
- Palatin Technologies, Inc.
- Start
- Dec 2021
- Primary completion
- Sep 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of PL9643 in dry eye disease (DED), sponsored by Palatin Technologies, Inc.. Started Dec 2021; status: completed.
02
Drugs
PL9643
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05201170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201170.